A Safety and Efficacy Study of DRM02 in Subjects With Rosacea

NCT01993446 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

Rosacea

Interventions

DRUG: DRM02
OTHER: Vehicle

Sponsor

Dermira, Inc.